Embecta Corp.

EMBC Healthcare Medical Instruments & Supplies

Embecta Corp.’s revenue for fiscal 2025 (year ended September 2025) was $1.1 billion, down 3.80% from fiscal 2024. In the quarter to June 2026, revenue fell 8.05%, EPS fell 53.9%, free cash flow fell 49.6% and total debt was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.

6.27 0.18 −2.79%
Market cap
$365.5M
P/E
4.2×
Fwd P/E
3.8×
Dividend yield
5.10%
F-score
7/9
Altman Z
1.84
Beneish M
−3.11
Dividend safety
56/100

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Sep '25 Sep '24 Sep '23 Sep '22 Dec '21 Sep '21 Dec '20 Sep '20 Sep '19
Revenue
1,080.40 1,123.10 1,120.80 1,129.50 289.30 1,165.30 285.30 1,085.50 1,109.00
Revenue Growth
(3.80%) 0.21% (0.77%) 290.43% (75.17%) 308.45% (73.72%) (2.12%) —
Gross Profit
676.80 735.20 749.90 774.90 203.90 800.40 191.30 762.60 786.00
Operating Income
242.10 166.80 221.50 309.60 116.60 492.00 124.10 486.50 —
EBT
136.30 44.20 105.70 256.60 116.60 494.90 125.10 485.80 500.00
Income after Tax
95.40 78.30 70.40 223.60 98.80 414.80 105.30 427.60 —
Net Income Common
95.40 78.30 70.40 223.60 98.80 414.80 105.30 427.60 432.00
EPS (Diluted)
1.62 1.34 1.22 3.89 — 7.28 — 7.50 —
Shares (Diluted, Weighted)
58.92 58.33 57.76 57.46 — 57.01 — 57.01 —
Gross Margin
62.64% 65.46% 66.91% 68.61% 70.48% 68.69% 67.05% 70.25% 70.87%
EBIT Margin
22.41% 14.85% 19.76% 27.41% 40.30% 42.22% 43.50% 44.82% 90.53%
Net Profit Margin
8.83% 6.97% 6.28% 19.80% 34.15% 35.60% 36.91% 39.39% 38.95%
Free Cash Flow Margin
16.88% 1.77% 3.68% 34.37% 46.49% 35.79% 38.56% 42.06% 45.54%
EBITDA
302.30 216.20 260.50 344.50 125.00 530.30 133.40 524.80 538.00
EBIT
242.10 166.80 221.50 309.60 116.60 492.00 124.10 486.50 1,004.00

Show all line items

In millions of $ except per-share values · columns are period end dates